What are the side effects of buspirone (anxiolytic medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Buspirone Side Effects

Buspirone's most common side effects include dizziness (12%), nausea (8%), headache (6%), nervousness (5%), and lightheadedness (3%), with approximately 10% of patients discontinuing treatment due to adverse events, primarily CNS disturbances. 1

Most Common Side Effects (≥1% incidence)

The FDA-approved labeling identifies the following frequently reported adverse effects in controlled clinical trials 1:

Central Nervous System Effects

  • Dizziness (12%) - most common side effect
  • Drowsiness (10%)
  • Nervousness (5%)
  • Insomnia (3%)
  • Lightheadedness (3%)
  • Decreased concentration (2%)
  • Excitement (2%)
  • Anger/hostility (2%)
  • Confusion (2%) 1

Gastrointestinal Effects

  • Nausea (8%) - second most common side effect
  • Dry mouth (3-4%)
  • Abdominal/gastric distress (2%)
  • Diarrhea (2%)
  • Constipation (1-2%)
  • Vomiting (1-2%) 1

Other Common Effects

  • Headache (6%)
  • Fatigue (4%)
  • Weakness (2%)
  • Tachycardia/palpitations (1%)
  • Blurred vision (2%) 1

Reasons for Treatment Discontinuation

Approximately 10% of patients discontinued buspirone in premarketing trials due to adverse events 1:

  • CNS disturbances (3.4%): primarily dizziness, insomnia, nervousness, drowsiness, and lightheadedness
  • GI disturbances (1.2%): primarily nausea
  • Miscellaneous (1.1%): primarily headache and fatigue
  • Multiple complaints (3.4%) 1

Less Common but Notable Side Effects

Infrequent Effects (1/100 to 1/1,000 patients) 1

  • Cardiovascular: syncope, hypotension, hypertension
  • CNS: depersonalization, dysphoria, euphoria, akathisia, hallucinations, involuntary movements, suicidal ideation, seizures
  • Sexual function: decreased or increased libido
  • Hepatic: increases in liver enzymes (SGOT, SGPT)
  • Musculoskeletal: muscle cramps, muscle spasms, rigid/stiff muscles 1

Rare Effects (<1/1,000 patients) 1

  • Serious cardiovascular: cerebrovascular accident, congestive heart failure, myocardial infarction, cardiomyopathy, bradycardia
  • CNS: stupor, slurred speech, psychosis
  • Hematologic: eosinophilia, leukopenia, thrombocytopenia 1

Postmarketing Reports

Additional adverse effects reported since market introduction include 1:

  • Allergic reactions (including urticaria)
  • Angioedema
  • Extrapyramidal symptoms and dyskinesias (acute and tardive)
  • Cogwheel rigidity and parkinsonism
  • Serotonin syndrome
  • Restless leg syndrome
  • Visual changes (including tunnel vision)
  • Urinary retention 1

Important Clinical Distinctions

Advantages Over Benzodiazepines

Buspirone notably lacks several side effects common to benzodiazepines 2, 3:

  • No sedation (or minimal sedation)
  • No muscle relaxation
  • No anticonvulsant effects
  • No psychomotor impairment when combined with alcohol or given alone
  • No abuse, dependence, or withdrawal symptoms reported 2, 3, 4

Neurochemical Effects

Buspirone increases peripheral levels of noradrenaline, dopamine, and free serotonin, which may contribute to both therapeutic and adverse effects 5. Small but significant decreases in systolic blood pressure and heart rate have been observed 5.

Critical Prescribing Considerations

Buspirone requires 2-4 weeks to become effective and is useful only in patients with mild to moderate agitation 6. The initial dosage typically starts at 5 mg twice daily, with a maximum recommended dosage of 20 mg three times daily 6.

Common Pitfall

Patients with previous long-term benzodiazepine exposure may experience reduced efficacy and increased dropout rates with buspirone, as the drug is not cross-tolerant with benzodiazepines 7. This is particularly important when transitioning patients from benzodiazepine therapy.

References

Research

Azaspirodecanediones in generalized anxiety disorder: buspirone.

Journal of affective disorders, 1987

Research

Effects of buspirone on plasma neurotransmitters in healthy subjects.

Journal of neural transmission (Vienna, Austria : 1996), 1998

Guideline

Buspirone Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.